Cargando…

Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge

Tuberculosis (TB) vaccine development has focused largely on targeting T helper type 1 (Th1) cells. However, despite inducing Th1 cells, the recombinant TB vaccine MVA85A failed to enhance protection against TB disease in humans. In recent years, Th17 cells have emerged as key players in vaccine-ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monin, Leticia, Griffiths, Kristin, Slight, Samantha, Lin, Yin-yao, Rangel-Moreno, Javier, Khader, Shabaana A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517980/ https://www.ncbi.nlm.nih.gov/pubmed/25627812 http://dx.doi.org/10.1038/mi.2014.136

Ejemplares similares

Unexpected Role for IL-17 in Protective Immunity against Hypervirulent Mycobacterium tuberculosis HN878 Infection
por: Gopal, Radha, et al.
Publicado: (2014)

Interleukin-17-dependent CXCL-13 mediates mucosal vaccine-induced immunity against tuberculosis
por: Gopal, Radha, et al.
Publicado: (2013)

A protocol to analyze single-cell RNA-seq data from Mycobacterium tuberculosis-infected mice lung
por: Akter, Sadia, et al.
Publicado: (2023)

CXCL17 Is Dispensable during Hypervirulent Mycobacterium tuberculosis HN878 Infection in Mice
por: Choreño-Parra, José Alberto, et al.
Publicado: (2021)

Profiling Early Lung Immune Responses in the Mouse Model of Tuberculosis
por: Kang, Dongwan D., et al.
Publicado: (2011)

The current state of animal models and genomic approaches towards identifying and validating molecular determinants of Mycobacterium tuberculosis infection and tuberculosis disease
por: Bucsan, Allison N, et al.
Publicado: (2019)

Formation of Lung Inducible Bronchus Associated Lymphoid Tissue Is Regulated by Mycobacterium tuberculosis Expressed Determinants
por: Dunlap, Micah D., et al.
Publicado: (2020)

Yin and yang of interleukin-17 in host immunity to infection
por: Das, Shibali, et al.
Publicado: (2017)

Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling
por: Obermajer, Nataša, et al.
Publicado: (2013)

Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection
por: Treerat, Puthayalai, et al.
Publicado: (2017)

Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection
por: Khader, Shabaana A., et al.
Publicado: (2006)

Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4(+) T Cell Activation and Mycobacterium tuberculosis Control
por: Das, Shibali, et al.
Publicado: (2021)

A novel role for C-C motif chemokine receptor 2 during infection with hypervirulent Mycobacterium tuberculosis
por: Dunlap, Micah D., et al.
Publicado: (2018)

Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy
por: Griffiths, Kristin L., et al.
Publicado: (2016)

Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production
por: Thirunavukkarasu, Shyamala, et al.
Publicado: (2023)

Th1/Th17 Cell Induction and Corresponding Reduction in ATP Consumption following Vaccination with the Novel Mycobacterium tuberculosis Vaccine MVA85A
por: Griffiths, Kristin L., et al.
Publicado: (2011)

Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis
por: Kaushal, Deepak, et al.
Publicado: (2015)

Development and stability of Th17 cells in ovarian cancer requires nitric oxide and endogenous NOS2 activity in cancer-associated CD4+ T cells
por: Obermajer, Natasa, et al.
Publicado: (2013)

Th17 cells confer long term adaptive immunity to oral mucosal Candida albicans infections
por: Hernández-Santos, Nydiaris, et al.
Publicado: (2012)

The development of inducible Bronchus Associated Lymphoid Tissue (iBALT) is dependent on IL-17
por: Rangel-Moreno, Javier, et al.
Publicado: (2011)

Mycobacterium tuberculosis TlyA Protein Negatively Regulates T Helper (Th) 1 and Th17 Differentiation and Promotes Tuberculosis Pathogenesis*
por: Rahman, Md. Aejazur, et al.
Publicado: (2015)

Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes
por: Akter, Sadia, et al.
Publicado: (2022)

Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis
por: Cruz, Andrea, et al.
Publicado: (2010)

Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection
por: Kumar, Nathella Pavan, et al.
Publicado: (2017)

Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice
por: Griffiths, Kristin L., et al.
Publicado: (2013)

The protective and pathogenic roles of CXCL17 in human health and disease: Potential in respiratory medicine
por: Choreño-Parra, José Alberto, et al.
Publicado: (2020)

Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes
por: Howard, Nicole C., et al.
Publicado: (2018)

PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection
por: Ashhurst, Anneliese S., et al.
Publicado: (2018)

Identification of Mycobacterium tuberculosis-Specific Th1, Th17 and Th22 Cells Using the Expression of CD40L in Tuberculous Pleurisy
por: Li, Li, et al.
Publicado: (2011)

Inhibition of IL-17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections
por: Kammüller, Michael, et al.
Publicado: (2017)

The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins
por: Safar, Hussain A., et al.
Publicado: (2020)

A novel therapeutic strategy of lipidated promiscuous peptide against Mycobacterium tuberculosis by eliciting Th1 and Th17 immunity of host
por: Rai, Pradeep K, et al.
Publicado: (2016)

IL‐32 and its splice variants are associated with protection against Mycobacterium tuberculosis infection and skewing of Th1/Th17 cytokines
por: Koeken, Valerie A. C. M., et al.
Publicado: (2019)

Mycobacterium tuberculosis RpfE-Induced Prostaglandin E2 in Dendritic Cells Induces Th1/Th17 Cell Differentiation
por: Park, Hye-Soo, et al.
Publicado: (2021)

Mycobacterium tuberculosis impedes CD40-dependent notch signaling to restrict Th(17) polarization during infection
por: Enriquez, Ana Beatriz, et al.
Publicado: (2022)

Response to Hypoxia and the Ensuing Dysregulation of Inflammation Impacts Mycobacterium tuberculosis Pathogenicity
por: Bucşan, Allison N., et al.
Publicado: (2022)

Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring rpoB mutation H445Y is associated with suppressed immunity through type I interferons
por: Bobba, Suhas, et al.
Publicado: (2023)

Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
por: Sharan, Riti, et al.
Publicado: (2022)

Combined Expression of IFN-γ, IL-17, and IL-4 mRNA by Recall PBMCs Moderately Discriminates Active Tuberculosis from Latent Mycobacterium tuberculosis Infection in Patients with Miscellaneous Inflammatory Underlying Conditions
por: Savolainen, Laura E., et al.
Publicado: (2016)

A novel adjuvant formulation induces robust Th1/Th17 memory and mucosal recall responses in Non-Human Primates
por: Woodworth, Joshua S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8n86m68gh700u5apg9s1dlpldo